Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ: TVGN )

1.110 +0.040 (+3.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 627,525
Open 1.080
Bid (Size) 1.070 (17)
Ask (Size) 1.110 (12)
Prev. Close 1.070
Today's Range 1.050 - 1.130
52wk Range 0.2556 - 6.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel
From Tevogen Bio Inc
Via GlobeNewswire

Performance

YTD
+4.72%
+4.72%
1 Month
-28.39%
-28.39%
3 Month
+8.82%
+8.82%
6 Month
+152.90%
+152.90%
1 Year
-83.37%
-83.37%

More News

Read More
Tevogen Bio's T-Cell Therapy Approach Stands Out, Analyst Sees Strong Potential
Via Benzinga
This Tevogen Bio Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
From Tevogen Bio Inc
Via GlobeNewswire
Which stocks are experiencing notable movement on Monday?
Via Chartmill
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
From Tevogen Bio Inc
Via GlobeNewswire
What's Going On With Tevogen Bio Stock Today?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
US Stock Futures Tumble As DeepSeek Buzz Jolts Big Tech: Expert Says The Chinese AI Model Is Yet To Prove Its Viability At Lower Cost In Long Term
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Topics Economy
Exposures Supply Chain
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference
From Tevogen Bio Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS